shRNA and siRNA delivery to the brain

The blood-brain barrier: Bottleneck in brain drug development

Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798 · see citing works

EGFR and cancer prognosis.

Nicholson, R., Gee, J., & Harper, M. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00231-3 · Cited by 2,132 · see citing works

Avidin

Green, N. M. (1975) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60411-8 · Cited by 1,472 · see citing works

Gene silencing in mammals by small interfering RNAs

McManus, M. T., & Sharp, P. A. (2002) · Nature Reviews Genetics · doi:10.1038/nrg908 · Cited by 1,400 · see citing works

Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?

Stein, C., & Cheng, Y. C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303 · see citing works

RNAi in Human Cells

Chiu, Y., & Rana, T. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00652-4 · Cited by 396 · see citing works

Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.

Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358 · see citing works

Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain Cancer

Zhang, Y., Zhang, Y., Bryant, J., Charles, A. C., Boado, R. J., & Pardridge, W. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0740 · Cited by 330 · see citing works

EGF mutant receptor vIII as a molecular target in cancer therapy.

Kuan, C., Wikstrand, C. J., & Bigner, D. D. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080083 · Cited by 325 · see citing works

Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate

Pardridge, W. M., Kang, Y., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 317 · see citing works

Targeting Rat Anti-Mouse Transferrin Receptor Monoclonal Antibodies through Blood-Brain Barrier in Mouse

Lee, H., Engelhardt, B., Lesley, J., Bickel, U., & Pardridge, W. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35388-1 · Cited by 287 · see citing works

Targeting Genes: Delivery and Persistent Expression of a Foreign Gene Driven by Mammalian Regulatory Elements in Vivo

Wu, C. H., Wilson, J. M., & Wu, G. Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71447-6 · Cited by 286 · see citing works

Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liver

Kwoh, D. Y., Coffin, C. C., Lollo, C. P., Jovenal, J., Banaszczyk, M., Mullen, P. M., Phillips, A. T., Amini, A., Fabrycki, J., Bartholomew, R. M., et al. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00274-7 · Cited by 276 · see citing works

Brain-specific expression of an exogenous gene after i.v. administration

Shi, N., Zhang, Y., Zhu, C., Boado, R. J., & Pardridge, W. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221450098 · Cited by 273 · see citing works

Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.

Cossum, P. A., Sasmor, H. M., Dellinger, D., Truong, L., Cummins, L. M., Owens, S. R., Markham, P. M., Shea, J. P., & Crooke, S. T. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39459-0 · Cited by 265 · see citing works

Noninvasive gene targeting to the brain

Shi, N., & Pardridge, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130187497 · Cited by 253 · see citing works

Neuroprotection with noninvasive neurotrophin delivery to the brain

Wu, D., & Pardridge, W. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.254 · Cited by 209 · see citing works

Transport Across the Primate Blood-Brain Barrier of a Genetically Engineered Chimeric Monoclonal Antibody to the Human Insulin Receptor

Coloma, M. J., Lee, H., Kurihara, A., Landaw, E. M., Boado, R. J., Morrison, S. L., & Pardridge, W. M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007592720793 · Cited by 207 · see citing works

Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.

Pardridge, W. M., Boado, R. J., & Kang, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5592 · Cited by 195 · see citing works

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

Zhang, Y., Calon, F., Zhu, C., Boado, R. J., & Pardridge, W. M. (2003) · Human Gene Therapy · doi:10.1089/10430340360464660 · Cited by 194 · see citing works

Global non-viral gene transfer to the primate brain following intravenous administration

Zhang, Y., Schlachetzki, F., & Pardridge, W. M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00018-7 · Cited by 179 · see citing works

Neuroprotection in Transient Focal Brain Ischemia After Delayed Intravenous Administration of Brain-Derived Neurotrophic Factor Conjugated to a Blood-Brain Barrier Drug Targeting System

Zhang, Y., & Pardridge, W. M. (2001) · Stroke · doi:10.1161/01.str.32.6.1378 · Cited by 175 · see citing works

Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages

Marcus-Sekura, C. J., Woerner, A. M., Shinozuka, K., Zon, G., & Quinnan, G. V. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.14.5749 · Cited by 175 · see citing works

Conjugation of brain-derived neurotrophic factor to a blood–brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin

Zhang, Y., & Pardridge, W. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03108-5 · Cited by 167 · see citing works

Rapid transferrin efflux from brain to blood across the blood–brain barrier

Zhang, Y., & Pardridge, W. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00222.x · Cited by 159 · see citing works

Receptor-Mediated Gene Targeting to Tissues In Vivo Following Intravenous Administration of Pegylated Immunoliposomes

Shi, N., Boado, R. J., & Pardridge, W. M. (2001) · Pharmaceutical Research · doi:10.1023/a:1010910523202 · Cited by 157 · see citing works

Brain Drug Targeting: The Future of Brain Drug Development

Pardridge, W. M. (2001) · Cited by 150 · see citing works

Antisense Gene Therapy of Brain Cancer with an Artificial Virus Gene Delivery System

Zhang, Y., Zhu, C., & Pardridge, W. M. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0633 · Cited by 144 · see citing works

Normalization of Striatal Tyrosine Hydroxylase and Reversal of Motor Impairment in Experimental Parkinsonism with Intravenous Nonviral Gene Therapy and a Brain-Specific Promoter

Zhang, Y., Schlachetzki, F., Zhang, Y.-F., Boado, R. J., & Pardridge, W. M. (2004) · Human Gene Therapy · doi:10.1089/104303404322959498 · Cited by 134 · see citing works

Receptor‐mediated delivery of an antisense gene to human brain cancer cells

Zhang, Y., Lee, H. J., Boado, R. J., & Pardridge, W. M. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.255 · Cited by 132 · see citing works

Enhanced Neuroprotective Effects of Basic Fibroblast Growth Factor in Regional Brain Ischemia after Conjugation to a Blood-Brain Barrier Delivery Vector

Song, B.-W., Vinters, H. V., Wu, D., & Pardridge, W. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.605 · Cited by 125 · see citing works

In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats

Zhang, Y., Boado, R. J., & Pardridge, W. M. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.449 · Cited by 113 · see citing works

Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin Receptor

Zhang, Y., & Pardridge, W. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082974 · Cited by 110 · see citing works

Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups

Tidd, D., & Warenius, H. M. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.283 · Cited by 108 · see citing works

An Antibody-Avidin Fusion Protein Specific for the Transferrin Receptor Serves as a Delivery Vehicle for Effective Brain Targeting: Initial Applications in Anti-HIV Antisense Drug Delivery to the Brain

Penichet, M. L., Kang, Y., Pardridge, W. M., Morrison, S. L., & Shin, S.-U. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4421 · Cited by 100 · see citing works

Contribution of Plasmid DNA to Hepatotoxicity after Systemic Administration of Lipoplexes

Loisel, S., Gall, C., Doucet, L., Férec, C., & Floch, V. (2001) · Human Gene Therapy · doi:10.1089/104303401300057405 · Cited by 98 · see citing works

Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer.

Zhang, Y., Schlachetzki, F., Li, J. Y., Boado, R. J., & Pardridge, W. M. (2003) · PubMed · Cited by 95 · see citing works

Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system.

Wu, D., & Pardridge, W. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20939-9 · Cited by 76 · see citing works

The effects of polycations on vascular permeability in the rat. A proposed role for charge sites.

Vehaskari, V. M., Chang, C. T., Stevens, J., & Robson, A. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111290 · Cited by 76 · see citing works

Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.

Suzuki, T., Wu, D., Schlachetzki, F., Li, J. Y., Boado, R. J., & Pardridge, W. M. (2004) · PubMed · Cited by 62 · see citing works

Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier.

Kurihara, A., & Pardridge, W. M. (1999) · PubMed · Cited by 61 · see citing works

PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli.

Abé, T., Terada, K., Wakimoto, H., Inoüe, R., Tyminski, E., Bookstein, R., Basilion, J. P., & Chiocca, E. A. (2003) · PubMed · Cited by 59 · see citing works

Insulin Receptors in Human Ocular Tissues

Naeser, P. (1997) · Upsala Journal of Medical Sciences · doi:10.3109/03009739709178930 · Cited by 57 · see citing works

CAPILLARY PERMEABILITY

(1927) · JAMA · doi:10.1001/jama.1927.02690210050017 · Cited by 54 · see citing works

Gene Targeting In Vivo with Pegylated Immunoliposomes

Pardridge, W. M. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)73032-8 · Cited by 53 · see citing works

Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.

Wu, D., Boado, R. J., & Pardridge, W. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12250-7 · Cited by 51 · see citing works

Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammation

Norman, J., Denham, W., Denham, D. W., Yang, J. W., Carter, G., Abouhamze, A. S., Tannahill, C., MacKay, S. L., & Moldawer, L. L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301240 · Cited by 47 · see citing works

Widespread expression of an exogenous gene in the eye after intravenous administration.

Zhu, C., Zhang, Y., & Pardridge, W. M. (2002) · PubMed · Cited by 44 · see citing works

Non–Sequence-Specific Inhibition of Transferrin Receptor Expression in HL-60 Leukemia Cells by Phosphorothioate Oligodeoxynucleotides

Ho, P. T., Ishiguro, K., Wickstrom, E., & Sartorelli, A. C. (1991) · Antisense Research and Development · doi:10.1089/ard.1991.1.329 · Cited by 42 · see citing works

Electron microscopic visualization of insulin translocation into the cytoplasm and nuclei of intact H35 hepatoma cells using covalently linked Nanogold-insulin

Shah, N., Zhang, S., Harada, S., Smith, R. M., & Jarett, L. (1995) · Endocrinology · doi:10.1210/endo.136.7.7789307 · Cited by 35 · see citing works

Free cationic liposomes inhibit the inflammatory response to cationic lipid–DNA complex injected intravenously and enhance its transfection efficiency

Elouahabi, A., Flamand, V., Özkan, S. A., Paulart, F., Vandenbranden, M., Goldman, M., & Ruysschaert, J. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00032-1 · Cited by 30 · see citing works

Organ‐specific expression of the lacZ gene controlled by the opsin promoter after intravenous gene administration in adult mice

Zhu, C., Zhang, Y., Zhang, Y., Li, J. Y., Boado, R. J., & Pardridge, W. M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.575 · Cited by 29 · see citing works

Decline in Exogenous Gene Expression in Primate Brain Following Intravenous Administration Is Due to Plasmid Degradation

Chu, C., Zhang, Y., Boado, R. J., & Pardridge, W. M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0274-x · Cited by 28 · see citing works

Brain Drug Targeting: The Future of Brain Drug Development

Dufresne, R. L. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a290 · Cited by 18 · see citing works

In vitro stability of α-Helical peptide nucleic acids (αPNAs)

Garner, P., Sherry, B. D., Moilanen, S. B., & Huang, Y. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00422-x · Cited by 12 · see citing works

Activatable Photosensitizers for Imaging and Therapy

Lovell, J. F., Liu, T. W. B., Chen, J., & Zheng, G. (2010) · Chemical Reviews · doi:10.1021/cr900236h · Cited by 1,718 · see citing works

The promises and pitfalls of RNA-interference-based therapeutics

Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,219 · see citing works

Delivery of siRNA Therapeutics: Barriers and Carriers

Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L. ‐. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 804 · see citing works

Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases

Gabathuler, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 804 · see citing works

Site-specific antibody drug conjugates for cancer therapy

Panowski, S. H., Bhakta, S., Raab, H. E., Polakis, P. G., & Junutula, J. R. (2013) · mAbs · doi:10.4161/mabs.27022 · Cited by 677 · see citing works

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging

Bhaskar, S. M. M., Tian, F., Stoeger, T., Kreyling, W. G., de la Fuente, J. M., Grazú, V., Borm, P. J. A., Estrada, G. G., Ntziachristos, V., & Razansky, D. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-3 · Cited by 497 · see citing works

Nonviral delivery of synthetic siRNAs in vivo

Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464 · see citing works

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305 · see citing works

Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)

Ulbrich, K., Knobloch, T., & Kreuter, J. (2011) · Journal of Drug Targeting · doi:10.3109/10611861003734001 · Cited by 259 · see citing works

Drug delivery of siRNA therapeutics: potentials and limits of nanosystems

Reischl, D., & Zimmer, A. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.06.001 · Cited by 253 · see citing works

The involvement of microRNAs in neurodegenerative diseases

Maciotta, S., Meregalli, M., & Torrente, Y. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00265 · Cited by 247 · see citing works

Nonviral methods for siRNA delivery

Gao, K., & Huang, L. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800134q · Cited by 244 · see citing works

Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing

Al‐Jamal, K. T., Gherardini, L. M., Bardi, G., Nunes, A., Guo, C., Bussy, C., Herrero, M. A., Bianco, A., Prato, M., Kostarelos, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100930108 · Cited by 240 · see citing works

Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes

Souto, E. B., & Müller, R. H. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_4 · Cited by 212 · see citing works

Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons

Bonoiu, A. C., Mahajan, S. D., Ding, H. Y., Roy, I., Yong, K., Kumar, R., Hu, R., Bergey, E. J., Schwartz, S. A., & Prasad, P. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901715106 · Cited by 204 · see citing works

Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications

Shilo, M., Motiei, M., Hana, P., & Popovtzer, R. (2013) · Nanoscale · doi:10.1039/c3nr04878k · Cited by 195 · see citing works

Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.

Kim, S.-S., Ye, C., Kumar, P., Chiu, I., Subramanya, S., Wu, H., Shankar, P., & Manjunath, N. (2010) · Molecular Therapy · doi:10.1038/mt.2010.27 · Cited by 164 · see citing works

Exosomal delivery of therapeutic modulators through the blood–brain barrier; promise and pitfalls

Heidarzadeh, M., Özdemir, Y., Kaya, M., Abriz, A. E., Zarebkohan, A., Rahbarghazi‬, R., & Sokullu, E. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00650-0 · Cited by 175 · see citing works

Targeted exosome coating gene-chem nanocomplex as “nanoscavenger” for clearing α-synuclein and immune activation of Parkinson’s disease

Liu, L., Li, Y., Peng, H., Liu, R., Ji, W., Shi, Z., Shen, J., Ma, G., & Zhang, X. (2020) · Science Advances · doi:10.1126/sciadv.aba3967 · Cited by 162 · see citing works

Antibody-Targeted Nanoparticles for Cancer Therapy

Fay, F., & Scott, C. J. (2011) · Immunotherapy · doi:10.2217/imt.11.5 · Cited by 160 · see citing works

Caveolae and transcytosis in endothelial cells: role in atherosclerosis

Frank, P. G., Pavlides, S., & Lisanti, M. P. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0659-8 · Cited by 155 · see citing works

Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes

Gu, J., Al-Bayati, K., & Ho, E. A. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0368-5 · Cited by 144 · see citing works

microRNAs: innovative targets for cerebral ischemia and stroke

Ouyang, Y.-B., Stary, C., Yang, G.-Y., & Giffard, R. (2012) · Current Drug Targets · doi:10.2174/138945013804806424 · Cited by 141 · see citing works

Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain

Kim, I., Lim, C., Kim, J., Nam, H. Y., Nam, K., Kim, S.-W., Park, J., & Lee, J.-K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.011 · Cited by 131 · see citing works

Learning from the past and looking to the future: emerging perspectives for improving the treatment of psychiatric disorders

Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132 · see citing works

Smart thermo-triggered squirting capsules for nanoparticle delivery

Liu, L., Wang, W., Ju, X., Xie, R., & Chu, L. (2010) · Soft Matter · doi:10.1039/c002231d · Cited by 130 · see citing works

Intravenous siRNA of Brain Cancer with Receptor Targeting and Avidin–Biotin Technology

Xia, C., Zhang, Y., Zhang, Y., Boado, R. J., & Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9460-8 · Cited by 128 · see citing works

Immunoconjugates and long circulating systems: Origins, current state of the art and future directions

Koshkaryev, A., Sawant, R. R., Deshpande, M., & Torchilin, V. P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.009 · Cited by 120 · see citing works

Oncogenic role of microRNAs in brain tumors

Pang, J. C., Kwok, W. K., Chen, Z., & Ng, H. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0525-0 · Cited by 120 · see citing works

MicroRNAs: regulators of oncogenesis and stemness

Papagiannakopoulos, T. Y., & Kosik, K. S. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-15 · Cited by 114 · see citing works

Strategies to assess blood–brain barrier penetration

Di, L., Kerns, E. H., & Carter, G. T. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.6.677 · Cited by 116 · see citing works

Strategies for targeted nonviral delivery of siRNAs in vivo

Kim, S. S., Garg, H., Joshi, A., & Manjunath, N. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.09.001 · Cited by 111 · see citing works

Intranasal drug delivery of small interfering RNA targeting Beclin1 encapsulated with polyethylenimine (PEI) in mouse brain to achieve HIV attenuation

Rodriguez, M., Lapierre, J., Ojha, C. R., Kaushik, A. K., Batrakova, E. V., Kashanchi, F., Dever, S. M., Nair, M., & El‐Hage, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-01819-9 · Cited by 106 · see citing works

Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases

Samaridou, E., Walgrave, H., Salta, E., Álvarez, D. M., Castro-López, V., Loza, M. I., & Alonso, M. J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119657 · Cited by 98 · see citing works

Differential receptor-mediated drug targeting to the diseased brain

Rip, J., Schenk, G., & de Boer, A. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902806383 · Cited by 98 · see citing works

Therapeutic reversal of Huntington’s disease by <i>in vivo</i> self-assembled siRNAs

Zhang, L., Wu, T., Shan, Y., Li, G., Ni, X., Chen, X., Hu, X., Lin, L., Li, Y., Guan, Y., et al. (2021) · Brain · doi:10.1093/brain/awab354 · Cited by 97 · see citing works

Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood–Brain Barrier by Using Different Transport Mechanisms

Song, J., Lu, C. T., Leszek, J., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810118 · Cited by 95 · see citing works

Nanoparticulate Systems for Drug Delivery and Targeting to the Central Nervous System

Craparo, E. F., Bondı̀, M. L., Pitarresi, G. L., & Cavallaro, G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00199.x · Cited by 94 · see citing works

Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells

Lujan, H., Griffin, W. C., Taube, J. H., & Sayes, C. M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s203330 · Cited by 92 · see citing works

Nanomedicine for Ischemic Stroke

Dong, X., Gao, J., Su, Y., & Wang, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207600 · Cited by 87 · see citing works

RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA

Aguiar, S. P., van der Gaag, B., & Cortese, F. A. B. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0101-9 · Cited by 83 · see citing works

RNA delivery biomaterials for the treatment of genetic and rare diseases

Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82 · see citing works

CYP-mediated drug metabolism in the brain impacts drug response

McMillan, D. M., & Tyndale, R. F. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.008 · Cited by 77 · see citing works

SREBP1 siRNA enhance the docetaxel effect based on a bone-cancer dual-targeting biomimetic nanosystem against bone metastatic castration-resistant prostate cancer

Chen, J., Wu, Z., Ding, W., Xiao, C., Zhang, Y., Gao, S., Gao, Y., & Cai, W. (2020) · Theranostics · doi:10.7150/thno.40489 · Cited by 75 · see citing works

REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy

Wang, H., Zhang, S., Wang, S., Lü, J., Wu, W., Weng, L., Chen, D., Zhang, Y., Lu, Z., Yang, H. J., et al. (2009) · Neuro-Oncology · doi:10.1215/15228517-2009-015 · Cited by 74 · see citing works

Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels

Morilla, M. J., Perez, A. P., Mundinio, C., & Romero, E. L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28261 · Cited by 74 · see citing works

Concepts in in vivo siRNA delivery for cancer therapy

Gondi, C. S., & Rao, J. S. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21790 · Cited by 73 · see citing works

In Vivo Delivery Aspects of miRNA, shRNA and siRNA

Khatri, N., Rathi, M. N., Baradia, D., Trehan, S., & Misra, A. R. (2012) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v29.i6.20 · Cited by 68 · see citing works

Plasmonic Nanostructures as Accelerators for Nanoparticles: Optical Nanocannon

Shalin, A. S., & Sukhov, S. V. (2012) · Plasmonics · doi:10.1007/s11468-012-9447-0 · Cited by 69 · see citing works

Delivery of small-interfering RNA (siRNA) to the brain

Mathupala, S. P. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770802680195 · Cited by 62 · see citing works

Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis

Tamaru, M., Akita, H., Fujiwara, T., Kajimoto, K., & Harashima, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.024 · Cited by 61 · see citing works

Biodegradable polymers in gene‐silencing technology

Hosseinkhani, H., & Domb, A. J. (2019) · Polymers for Advanced Technologies · doi:10.1002/pat.4713 · Cited by 58 · see citing works

Therapeutic face of RNAi:in vivochallenges

Borna, H., İmani, S., Iman, M., & Jamalkandi, S. A. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.983070 · Cited by 57 · see citing works

Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance

Rhaman, M. M., Islam, M. R., Akash, S., Mim, M., Noor alam, M., Nepovimova, E., Valis, M., Kuca, K., & Sharma, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.989471 · Cited by 63 · see citing works

RNAi Therapeutics and Applications of MicroRNAs in Cancer Treatment

Uchino, K., Ochiya, T., & Takeshita, F. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt052 · Cited by 56 · see citing works

Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood–Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro

Rodriguez, M., Kaushik, A. K., Lapierre, J., Dever, S. M., El‐Hage, N., & Nair, M. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9688-3 · Cited by 56 · see citing works

Gold Nanorod–siRNA Induces Efficient In Vivo Gene Silencing in The Rat Hippocampus

Bonoiu, A. C., Bergey, E. J., Ding, H. Y., Hu, R., Kumar, R., Yong, K., Prasad, P. N., Mahajan, S. D., Picchione, K. E., Bhattacharjee, A., et al. (2011) · Nanomedicine · doi:10.2217/nnm.11.20 · Cited by 54 · see citing works

Potential use of RNA interference in cancer therapy

Phalon, C., Rao, D. D., & Nemunaitis, J. J. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001584 · Cited by 52 · see citing works

Synthesis, photophysics and photochemistry of phthalocyanine-ɛ-polylysine conjugates in the presence of metal nanoparticles against Staphylococcus aureus

Nombona, N., Antunes, E. M., Chidawanyika, W., Kleyi, P. E., Tshentu, Z. R., & Nyokong, T. (2012) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2012.02.012 · Cited by 51 · see citing works

Delivering a disease-modifying treatment for Huntington's disease

Godinho, B. M. D. C., Malhotra, M., O’Driscoll, C. M., & Cryan, J. F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.011 · Cited by 47 · see citing works

RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges

Lee, J. W., Shim, M. K., Kim, H., Jang, H., Lee, Y., & Kim, S. H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115073 · Cited by 46 · see citing works

Single Reporter for Targeted Multimodal in Vivo Imaging

Niers, J. M., Chen, J. W., Lewandrowski, G. K., Kerami, M., Garanger, É., Wojtkiewicz, G. R., Waterman, P. R., Keliher, E. J., Weissleder, R., & Tannous, B. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209868g · Cited by 46 · see citing works

Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression

Hsu, C. Y. M., & Uludağ, H. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.655247 · Cited by 46 · see citing works

Neuroprotective Effects of MicroRNA-210 on Hypoxic-Ischemic Encephalopathy

Qiu, J., Zhou, X., Zhou, X., Cheng, R., Liu, H., & Li, Y. (2013) · BioMed Research International · doi:10.1155/2013/350419 · Cited by 45 · see citing works

Quantitative analysis of the brain-targeted delivery of drugs and model compounds using nano-delivery systems

Kozlovskaya, L., & Stepensky, D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.028 · Cited by 45 · see citing works

An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells

Rizk, S. S., Łuchniak, A., Uysal, S., Brawley, C. M., Rock, R. S., & Kossiakoff, A. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904907106 · Cited by 44 · see citing works

Click synthesis of a polyamidoamine dendrimer-based camptothecin prodrug

Zolotarskaya, O. Y., Xu, L., Valerie, K. C., & Yang, H. (2015) · RSC Advances · doi:10.1039/c5ra07987j · Cited by 40 · see citing works

Polyion complex micelles composed of pegylated polyasparthydrazide derivatives for siRNA delivery to the brain

Huo, H., Gao, Y., Wang, Y., Zhang, J., Wang, Z., Jiang, T., & Wang, S. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2015.01.043 · Cited by 40 · see citing works

Knockdown of tyrosine hydroxylase in the nucleus of the solitary tract reduces elevated blood pressure during chronic intermittent hypoxia

Bathina, C. S., Rajulapati, A., Franzke, M., Yamamoto, K., Cunningham, J. T., & Mifflin, S. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00260.2013 · Cited by 39 · see citing works

Neuroprotective effects of microRNA-210 against oxygen-glucose deprivation through inhibition of apoptosis in PC12 cells

Qiu, J., Zhou, X., Zhou, X., Cheng, R., Liu, H., & Li, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1431 · Cited by 38 · see citing works

Strategies for short hairpin RNA delivery in cancer gene therapy

Wang, S., Yao, H., & Qin, Z. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903236843 · Cited by 38 · see citing works

Nanocarrier possibilities for functional targeting of bioactive peptides and proteins:state-of-the-art

Moutinho, C. M. S. G., Matos, C. M., Teixeira, J. A., & Balcão, V. M. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.628397 · Cited by 38 · see citing works

Genetic approach for intracerebroventricular delivery

Regev, L., Ezrielev, E., Gershon, E., Gil, S., & Chen, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907059107 · Cited by 35 · see citing works

A simple, noninvasive and efficient method for transdermal delivery of siRNA

Lin, C., Huang, K., Zeng, Y., Chen, X., Wang, S., & Li, Y. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1181-5 · Cited by 34 · see citing works

Vessel microport technique for applications in cerebrovascular research

Chen, L., Swartz, K. R., & Toborek, M. J. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21973 · Cited by 34 · see citing works

Delivery of RNAi therapeutics: work in progress

Miller, A. D. (2013) · Expert Review of Medical Devices · doi:10.1586/17434440.2013.855471 · Cited by 34 · see citing works

Development of New Peptide Vectors for the Transport of Therapeutic Across the blood–brain Barrier

Gabathuler, R. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.35 · Cited by 33 · see citing works

Emerging therapies for neuropathic lysosomal storage disorders

Kelly, J. M., Bradbury, A. M., Martin, D. R., & Byrne, M. E. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.002 · Cited by 32 · see citing works

Physiology of the Blood–Brain Barrier and Mechanisms of Transport Across the BBB

Lalatsa, A., & Butt, A. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00003-8 · Cited by 31 · see citing works

Multifunctional Gold Nanorod for Therapeutic Applications and Pharmaceutical Delivery Considering Cellular Metabolic Responses, Oxidative Stress and Cellular Longevity

Mousavi, S. M., Hashemi, S. A., Mazraedoost, S., Yousefi, K., Gholami, A., Behbudi, G., Ramakrishna, S., Omidifar, N., Alizadeh, A. A., & Chiang, W. (2021) · Nanomaterials · doi:10.3390/nano11071868 · Cited by 31 · see citing works

Targeted Delivery of siRNA Therapeutics to Malignant Tumors

Leng, Q., Woodle, M. C., & Mixson, A. J. (2017) · Journal of Drug Delivery · doi:10.1155/2017/6971297 · Cited by 30 · see citing works

Novel siRNA delivery strategy: a new "strand" in CNS translational medicine?

Gherardini, L., Bardi, G., Gennaro, M., & Pizzorusso, T. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1310-8 · Cited by 28 · see citing works

Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier

Sharma, R. K., Calderon, C., & Vivas‐Mejía, P. E. (2021) · Frontiers in Medical Technology · doi:10.3389/fmedt.2021.678593 · Cited by 28 · see citing works

Physicochemical properties of a zinc phthalocyanine – pyrene conjugate adsorbed onto single walled carbon nanotubes

Ogbodu, R. O., Antunes, E. M., & Nyokong, T. (2013) · Dalton Transactions · doi:10.1039/c3dt50335f · Cited by 28 · see citing works

Genetically Engineered Clostridial C2 Toxin as a Novel Delivery System for Living Mammalian Cells

Fahrer, J., Plunien, R., Binder, U., Langer, T., SELIGER, H., & Barth, H. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900365b · Cited by 27 · see citing works

MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours

Garg, N., Vijayakumar, T., Bakhshinyan, D., Venugopal, C., & Singh, S. K. (2015) · Stem Cells International · doi:10.1155/2015/141793 · Cited by 26 · see citing works

Drug Delivery Across the Blood–Brain Barrier

Lalatsa, A., Schätzlein, A. G., & Uchegbu, I. F. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00180-x · Cited by 26 · see citing works

Gene Therapies for Polyglutamine Diseases

Matos, C. A., Carmona, V., Vijayakumar, U. G., Lopes, S., Albuquerque, P., Conceição, M., Nobre, R. J., Nóbrega, C., & de Almeida, L. P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_20 · Cited by 25 · see citing works

Microenvironment-tailored micelles restrain carcinoma-astrocyte crosstalk for brain metastasis

Zhao, Z., Zhang, Y., Li, C., Li, X., Chu, Y., Guo, Q., Zhang, Y., Xia, W., Liu, P., Chen, H., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.009 · Cited by 24 · see citing works

Genetic mouse models for behavioral analysis through transgenic RNAi technology

Delic, S., Streif, S., Deussing, J. M., Weber, P., Ueffing, M., Hölter, S. M., Wurst, W., & Kühn, R. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00412.x · Cited by 24 · see citing works

Improved method for synthesis of low molecular weight protamine–siRNA conjugate

Yu, Z., Ye, J., Pei, X., Sun, L., Liu, E., Wang, J., Huang, Y., Lee, S. J., & He, H. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.011 · Cited by 24 · see citing works

Chitosan and its derivatives as nanocarriers for siRNA delivery

Al‐Qadi, S., Grenha, A., & Remuñán‐López, C. (2012) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(12)50003-1 · Cited by 20 · see citing works

Specific knock-down of GAD67 in the striatum using naked small interfering RNAs

Manrique, C., Compan, V., Rosselet, C., & Gustave, S. D. D. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.05.009 · Cited by 18 · see citing works

Activation of cyclin D1 affects mitochondrial mass following traumatic brain injury

Saha, P., Gupta, R. K., Sen, T., & Sen, N. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.010 · Cited by 17 · see citing works

Cellular Uptake of Fluorescent Labelled Biotin–Streptavidin Microspheres

Bradley, M., Alexander, L. M., & Sanchez-Martin, R. M. (2008) · Journal of Fluorescence · doi:10.1007/s10895-008-0334-1 · Cited by 17 · see citing works

Targeting individual calpain isoforms for neuroprotection

Geddes, J. W., & Saatman, K. E. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.07.025 · Cited by 16 · see citing works

Drug Delivery to the Brain Via the blood–brain Barrier: a Review of the Literature and Some Recent Patent Disclosures

Tucker, I. G. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.3 · Cited by 16 · see citing works

Elevated plasma CaM expression in patients with acute cerebral infarction predicts poor outcomes and is inversely associated with miR-26b expression

Yuan, M., Tang, Y., Zhou, C., Liu, F., Chen, L., & Yuan, H. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1020537 · Cited by 16 · see citing works

In vivo self-assembled siRNAs within small extracellular vesicles attenuate LRRK2-induced neurodegeneration in Parkinson's disease models

Zhang, L., Chen, P., Chen, T., Lin, L., Ji, X., Liu, J., Huang, H., Saravanan, T., Fuehrer, H., Ross, C. A., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.045 · Cited by 14 · see citing works

Targeted Systemic Delivery of Therapeutic siRNA

Gujrati, M. D., & Lu, Z. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394295-1.00004-4 · Cited by 14 · see citing works

In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats

Zhang, Y., Boado, R. J., & Pardridge, W. M. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.449 · Cited by 113 · see citing works

Intravenous, non-viral RNAi gene therapy of brain cancer

Pardridge, W. M. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1103 · Cited by 105 · see citing works

Delivering RNA Interference to the Mammalian Brain

Fountaine, T. M., Wood, M. J. A., & Wade‐Martins, R. (2005) · Current Gene Therapy · doi:10.2174/1566523054546206 · Cited by 54 · see citing works

Intravenous siRNA of Brain Cancer with Receptor Targeting and Avidin–Biotin Technology

Xia, C., Zhang, Y., Zhang, Y., Boado, R. J., & Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9460-8 · Cited by 128 · see citing works

Entry granted

Cantin, E. M., & Rossi, J. J. (2007) · Nature · doi:10.1038/448033a · Cited by 6 · see citing works